Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2022 | 2019 | 2017 | 2016
Number of items: 5.

2022

Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elisa, Fox, Christopher P., Schorb, Elisabeth, Celico, Claudia, Falautano, Monica, Nonis, Alessandro, La Rosee, Paul ORCID: 0000-0002-6758-7809, Binder, Mascia, Fabbri, Alberto, Ilariucci, Fiorella, Krampera, Mauro, Roth, Alexander, Hemmaway, Claire, Johnson, Peter W., Linton, Kim M., Pukrop, Tobias, Gorlov, Jettes Sonderskov, Balzarotti, Monica, Hess, Georg, Keller, Ulrich, Stilgenbauer, Stephan, Panse, Jense, Tucci, Alessandra, Orsucci, Lorella, Pisani, Francesco, Zanni, Manuela, Krause, Stefan W., Schmoll, Hans J., Hertenstein, Bernd, Rummel, Mathias, Smith, Jeffery, Thurner, Lorenz, Cabras, Giuseppina, Pennese, Elsa, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S., Finke, Jurgen, Ferranti, Antonella, Cozens, Kelly, Burger, Elvira, Ielmini, Nicoletta, Cavalli, Franco, Zucca, Emanuele and Illerhaus, Gerald (2022). Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial. Leukemia, 36 (7). S. 1870 - 1879. LONDON: SPRINGERNATURE. ISSN 1476-5551

2019

Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Borchmann, Peter, Viardot, Andreas, Soekler, Martin, Keller, Ulrich, Schmidt, Christian, Truemper, Lorenz, Mahlberg, Rolf, Marks, Reinhard, Hoeffkes, Heinz-Gert, Metzner, Bernd, Dierlamm, Judith, Frickhofen, Norbert, Haenel, Mathias, Neubauer, Andreas, Kneba, Michael, Merli, Francesco, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Brown, Peter de Nully ORCID: 0000-0002-6522-4086, Federico, Massimo, Lengfelder, Eva, di Rocco, Alice, Trappe, Ralf ORCID: 0000-0001-7565-7160, Rosenwald, Andreas, Berdel, Christian, Maisenhoelder, Martin, Shpilberg, Ofer, Amam, Josif, Christofyllakis, Konstantinos ORCID: 0000-0002-0308-388X, Hartmann, Frank, Murawski, Niels, Stilgenbauer, Stephan, Nickelsen, Maike, Wulf, Gerald, Glass, Bertram, Schmitz, Norbert, Altmann, Bettina, Loeffler, Markus and Pfreundschuh, Michael (2019). Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Lancet, 394 (10216). S. 2271 - 2282. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

2017

Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elisa, Fox, Christopher P., Schorb, Elisabeth, La Rosee, Paul, Binder, Mascha ORCID: 0000-0003-0663-3004, Fabbri, Alberto, Torri, Valter ORCID: 0000-0001-9541-9354, Minacapelli, Eleonora, Falautano, Monica, Ilariucci, Fiorella, Ambrosetti, Achille, Roth, Alexander, Hemmaway, Claire, Johnson, Peter ORCID: 0000-0003-2306-4974, Linton, Kim M., Pukrop, Tobias, Gorlov, Jette Sonderskov, Balzarotti, Monica, Hess, Georg, Keller, Ulrich, Stilgenbauer, Stephan, Panse, Jens, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Orsucci, Lorella, Pisani, Francesco, Levis, Alessandro, Krause, Stefan W., Schmoll, Hans J., Hertenstein, Bernd, Rummel, Mathias, Smith, Jeffery, Pfreundschuh, Michael, Cabras, Giuseppina, Angrilli, Francesco, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S., Finke, Juergen, Reni, Michele, Cavalli, Franco, Zucca, Emanuele ORCID: 0000-0002-5522-6109 and Illerhaus, Gerald (2017). Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. Lancet Haematol., 4 (11). S. E510 - 14. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

2016

Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elisa Jacobsen, Fox, Christopher P., Schorb, Elisabeth, La Rosee, Paul, Binder, Mascha, Fabbri, Alberto, Torri, Valter ORCID: 0000-0001-9541-9354, Minacapelli, Eleonora, Falautano, Monica, Ilariucci, Fiorella, Ambrosetti, Achille, Roth, Alexander, Hemmaway, Claire Jane, Johnson, Peter M., Linton, Kim, Pukrop, Tobias, Gorlov, Jette Sonderskov, Balzarotti, Monica, Hess, Georg, Keller, Ulrich, Stilgenbauer, Stephan, Panse, Jens P., Tucci, Alessandra, Orsucci, Lorella, Pisani, Francesco, Levis, Alessandro, Krause, Stefan W., Schmoll, Hans-Joachim, Hertenstein, Bernd, Rummel, Mathias, Smith, Jeffery, Pfreundschuh, Michael, Cabras, Giuseppina, Angrilli, Francesco, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S., Finke, Jurgen, Reni, Michele, Cavalli, Franco, Zucca, Emanuele and Illerhaus, Gerald (2016). Effects on Survival and Neurocognitive Functions of Whole-Brain Radiotherapy (WBRT) and Autologous Stem Cell Transplantation (ASCT) as Consolidation Options after High-Dose Methotrexate-Based Chemoimmunotherapy in Patients with Newly Diagnosed Primary CNS Lymphoma (PCNSL): Results of the Second Randomization of the IELSG32 Trial. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elko, Ponzoni, Mourilio, Deckert, Martina, Politi, Letterio S., Torri, Valter ORCID: 0000-0001-9541-9354, Fox, Christopher P., La Rosee, Paul ORCID: 0000-0002-6758-7809, Schorb, Elisabeth, Ambrosetti, Achille, Roth, Alexander, Hemmoway, Claire, Ferrari, Angela ORCID: 0000-0002-9984-1146, Linton, Kim M., Ruda, Roberta, Binder, Mascha ORCID: 0000-0003-0663-3004, Pukrop, Tobias, Balzarotti, Monica, Fabbri, Alberto, Johnson, Peter, Gorlov, Jette Sonderskov, Hess, Georg, Panse, Jens, Pisani, Francesco, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Stilgenbauer, Stephan, Hertenstein, Bernd, Keller, Ulrich, Krause, Stefan W., Levis, Alessandro, Schmoll, Hans J., Covalli, Franco, Finke, Jurgen, Reni, Michele ORCID: 0000-0002-6463-0293, Zucca, Emanuele ORCID: 0000-0002-5522-6109 and Illerhaus, Gerald (2016). Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol., 3 (5). S. E217 - 11. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

This list was generated on Fri Mar 29 13:33:53 2024 CET.